Study Evaluating the Pharmacokinetics of the Potential Drug Interaction Between HCV-796 and Desipramine

Wyeth

Status and phase: Completed; Phase 1

Conditions: Healthy

Treatments: Drug: HCV-796; Drug: Desipramine

Study type: Interventional

Funder types: Industry

Identifiers

NCT00500721

3173A1-1120

Details and patient eligibility

About

To evaluate the potential pharmacokinetic (PK) interaction of multiple oral doses of HCV-796 and a single dose of desipramine when coadministered to healthy subjects.

Enrollment: 22 estimated patients

Sex: All

Ages: 18 to 50 years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Healthy as determined by the investigator on the basis of medical history, physical examination, clinical laboratory test results, vital signs, and 12-lead ECG.